Publications by year
2023
Duggan S, Usher J (2023). Candida glabrata: a powerhouse of resistance.
PLoS Pathog,
19(10).
Author URL.
Douglas EJA, Marshall B, Alghamadi A, Joseph EA, Duggan S, Vittorio S, De Luca L, Serpi M, Laabei M (2023). Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function.
ACS Infect Dis,
9(11), 2141-2159.
Abstract:
Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function.
The lipoteichoic acid (LTA) biosynthesis pathway has emerged as a promising antimicrobial therapeutic target. Previous studies identified the 1,3,4 oxadiazole compound 1771 as an LTA inhibitor with activity against Gram-positive pathogens. We have succeeded in making six 1771 derivatives and, through subsequent hit validation, identified the incorporation of a pentafluorosulfanyl substituent as central in enhancing activity. Our newly described derivative, compound 13, showed a 16- to 32-fold increase in activity compared to 1771 when tested against a cohort of multidrug-resistant Staphylococcus aureus strains while simultaneously exhibiting an improved toxicity profile against mammalian cells. Molecular techniques were employed in which the assumed target, lipoteichoic acid synthase (LtaS), was both deleted and overexpressed. Neither deletion nor overexpression of LtaS altered 1771 or compound 13 susceptibility; however, overexpression of LtaS increased the MIC of Congo red, a previously identified LtaS inhibitor. These data were further supported by comparing the docking poses of 1771 and derivatives in the LtaS active site, which indicated the possibility of an additional target(s). Finally, we show that both 1771 and compound 13 have activity that is independent of LtaS, extending to cover Gram-negative species if the outer membrane is first permeabilized, challenging the classification that these compounds are strict LtaS inhibitors.
Abstract.
Author URL.
Bonini D, Duggan S, Alnahari A, Brignoli T, Strahl H, Massey R (2023). Lipoteichoic acid biosynthesis by<i>Staphylococcus aureus</i>is controlled by the MspA protein through competitive interference.
Abstract:
Lipoteichoic acid biosynthesis byStaphylococcus aureusis controlled by the MspA protein through competitive interference
ABSTRACT Staphylococcus aureus produces a plethora of virulence factors critical to its ability to establish an infection and cause disease. We have previously characterised a small membrane protein, MspA, which has pleiotropic affects on virulence and contributes to S. aureus pathogenicity in vivo. Here we report that mspA inactivation triggers overaccumulation of the essential cell wall component lipoteichoic acid (LTA) which, in turn, decreases autolytic activity and leads to increased cell size due to a delay in cell separation. We show that MspA directly interacts with the LTA synthesis enzymes UgtP, LtaA and LtaS, and competitively interferes with the association between LtaA and LtaS. While complementation of the mspA mutant with wild-type mspA reduces the amount of LTA, expression of a mutated version of MspA that does not interfere with the interactions between LtaA and LtaS does not. We suggest that MspA contributes to maintaining a physiological level of LTA in the cell wall by interacting with the LTA synthetic enzymes. In conclusion, this study uncovers the critical role of the MspA protein in regulating cell envelope biosynthesis and pathogenicity. IMPORTANCE the S. aureus cell envelope, comprising of the cytoplasmic membrane, a thick peptidoglycan layer and the anionic polymers lipoteichoic acid and wall teichoic acids, is fundamental for bacterial growth and division, as well as being the main interface between the pathogen and the host. It has become increasingly apparent that the synthesis and turnover of cell envelope components also affect the virulence of S. aureus. In this study, we show that MspA, a novel effector of S. aureus virulence, contributes to the maintenance of normal levels of lipoteichoic acid in the cell wall, with implications on cell cycle and size. These findings further our understanding of the connections between envelope synthesis and pathogenicity and suggests MspA as a novel a target for therapeutic intervention.
Abstract.
2022
Laabei M, Duggan S (2022). CidA and LrgA: a "Hole" Lot More than Programmed Cell Death.
mBio,
13(3).
Abstract:
CidA and LrgA: a "Hole" Lot More than Programmed Cell Death.
What do programmed cell death (PCD) and carbohydrate metabolism by-product transport have in common? Intriguingly, both processes involve the cidABC and lrgAB operons in the major human pathogen Staphylococcus aureus. Previously, CidA and LrgA have been studied in the context of programmed cell death, but a second function in overflow metabolism is increasingly evident. New work from J. L. Endres, S. S. Chaudhari, X. Zhang, J. Prahlad, et al. (mBio 13:e02827-21, 2022, https://doi.org/10.1128/mBio.02827-21) combining a lysis cassette, mutagenesis, and classic microbiology demonstrates that CidA and LrgA function as holins to support endolysin-induced lysis. But that's not all-the lrgAB operon also facilitates pyruvate uptake during microaerobic and anaerobic growth. This commentary highlights the main findings from this work and places them in context of the literature to date. Finally, as these proteins are highly conserved and carry out disparate functions of great importance, it is tempting to speculate future work will elucidate the link between S. aureus lysis and pyruvate metabolism.
Abstract.
Author URL.
Stevens EJ, Morse DJ, Bonini D, Duggan S, Brignoli T, Recker M, Lees JA, Croucher NJ, Bentley S, Wilson DJ, et al (2022). Targeted control of pneumolysin production by a mobile genetic element in Streptococcus pneumoniae.
Microb Genom,
8(4).
Abstract:
Targeted control of pneumolysin production by a mobile genetic element in Streptococcus pneumoniae.
Streptococcus pneumoniae is a major human pathogen that can cause severe invasive diseases such as pneumonia, septicaemia and meningitis. Young children are at a particularly high risk, with an estimated 3-4 million cases of severe disease and between 300 000 and 500 000 deaths attributable to pneumococcal disease each year. The haemolytic toxin pneumolysin (Ply) is a primary virulence factor for this bacterium, yet despite its key role in pathogenesis, immune evasion and transmission, the regulation of Ply production is not well defined. Using a genome-wide association approach, we identified a large number of potential affectors of Ply activity, including a gene acquired horizontally on the antibiotic resistance-conferring Integrative and Conjugative Element (ICE) ICESp23FST81. This gene encodes a novel modular protein, ZomB, which has an N-terminal UvrD-like helicase domain followed by two Cas4-like domains with potent ATP-dependent nuclease activity. We found the regulatory effect of ZomB to be specific for the ply operon, potentially mediated by its high affinity for the BOX repeats encoded therein. Using a murine model of pneumococcal colonization, we further demonstrate that a ZomB mutant strain colonizes both the upper respiratory tract and lungs at higher levels when compared to the wild-type strain. While the antibiotic resistance-conferring aspects of ICESp23FST81 are often credited with contributing to the success of the S. pneumoniae lineages that acquire it, its ability to control the expression of a major virulence factor implicated in bacterial transmission is also likely to have played an important role.
Abstract.
Author URL.
Brignoli T, Douglas E, Duggan S, Fagunloye OG, Adhikari R, Aman MJ, Massey RC (2022). Wall Teichoic Acids Facilitate the Release of Toxins from the Surface of Staphylococcus aureus.
Microbiology Spectrum,
10(4).
Abstract:
Wall Teichoic Acids Facilitate the Release of Toxins from the Surface of Staphylococcus aureus
. The production and release of cytolytic toxins is a critical aspect for the pathogenicity of many bacterial pathogens. In this study, we demonstrate a role for wall teichoic acids, molecules that are anchored to the peptidoglycan of the bacterial cell wall, in the release of toxins from
. S. aureus
. cells into the extracellular environment.
.
Abstract.
Brignoli T, Douglas E, Duggan S, Fagunloye OG, Adhikari R, Aman MJ, Massey RC (2022). Wall teichoic acids facilitate the release of toxins from the surface of <i>Staphylococcus aureus</i>.
Abstract:
Wall teichoic acids facilitate the release of toxins from the surface of Staphylococcus aureus
AbstractA major feature of the pathogenicity of Staphylococcus aureus is its ability to secrete cytolytic toxins. This process involves the translocation of the toxins from the cytoplasm, through the bacterial membrane and the cell wall to the external environment. The process of their movement through the membrane is relatively well defined, involving both general and toxin-specific secretory systems. Movement of the toxins through the cell wall was considered to involve the passive diffusion of the proteins through the porous cell wall structures, however, recent work suggests that this is more complex, and here we demonstrate a role for the wall teichoic acids (WTA) in this process. Utilising a genome-wide association approach we identified a polymorphism in the locus encoding the WTA biosynthetic machinery as associated with the cytolytic activity of the bacteria. We verified this association using an isogenic mutant set and found that WTA is required for the release of several cytolytic toxins from the bacterial cells. We show this effect is mediated by a change in the electrostatic charge across the cell envelope that results from the loss of WTA. As a major target for the development of novel therapeutics, it is important that we fully understand the entire process of cytolytic toxin production and release. These findings open up a new aspect to this process that requires in-depth investigation, while also demonstrating that clinical isolates can utilise WTA production to vary their cytotoxicity, thereby altering their pathogenic capabilities.ImportanceThe production and release of cytolytic toxins is a critical aspect to the pathogenicity of many bacterial pathogens. In this study we demonstrate a role for wall teichoic acids, molecules that are anchored to the peptidoglycan of the bacterial cell wall, in the release of toxins from S. aueus cells into the extracellular environment. Our findings suggest this effect is mediated by a gradient of electrostatic charge the presence of the negatively charged WTA molecules create across the cell envelope. This work brings an entirely new aspect to our understanding of the cytotoxicity of S. aureus and demonstrates a further means by which this major human pathogen can adapt its pathogenic capabilities.
Abstract.
2021
Douglas EJA, Duggan S, Brignoli T, Massey RC (2021). The MpsB protein contributes to both the toxicity and immune evasion capacity of <i>Staphylococcus aureus</i>.
MICROBIOLOGY-SGM,
167(10).
Author URL.
2020
Duggan S, Laabei M, Alnahari AA, O'Brien EC, Lacey KA, Bacon L, Heesom K, Fu C-L, Otto M, Skaar E, et al (2020). A Small Membrane Stabilizing Protein Critical to the Pathogenicity of <i>Staphylococcus aureus</i>.
INFECTION AND IMMUNITY,
88(9).
Author URL.
Stevens EJ, Morse DJ, Bonini D, Duggan S, Brignoli T, Recker M, Lees JA, Croucher NJ, Bentley S, Wilson DJ, et al (2020). Targeted control of pneumolysin production by a mobile genetic element in Streptococcus pneumoniae.
2019
Duggan S, Laabei M, Alnahari A, O’Brien EC, Lacey KA, Bacon L, Heesom K, Fu C-L, Otto M, Skaar E, et al (2019). A small membrane protein critical to both the offensive and defensive capabilities of <i>Staphylococcus aureus</i>.
Abstract:
A small membrane protein critical to both the offensive and defensive capabilities of Staphylococcus aureus
AbstractStaphylococcus aureus is a major human pathogen, where the widespread emergence of antibiotic resistance is making infections more challenging to treat. Toxin induced tissue damage and resistance to the host’s immune system are well established as critical to its ability to cause disease. However, recent attempts to study S. aureus pathogenicity at a population level have revealed significant complexity and hierarchical levels of regulation. In an effort to better understand this we have identified and characterized a principle effector protein, MasA. The inactivation of this small highly-conserved membrane protein simultaneously disrupts toxin production and impairs S. aureus’ ability to resist several aspects of the innate immune system. These pleiotropic effects are mediated by both a change in the stability of the bacterial membrane and the dysregulation of iron homeostasis, which results in a significant impairment in the ability of S. aureus to cause infection in both a subcutaneous and a sepsis model of infection. That proteins with such major effects on pathogenicity remain unidentified in a bacterium as well studied as S. aureus demonstrates how incomplete our understanding of their ability to cause disease is, an issue that needs to be addressed if effective control and treatment strategies are to be developed.
Abstract.
2015
Herzog S, Aly M, Duggan S, Linde J, Martin R, Kurzai O (2015). A network of heat shock-associated genes is up-regulated during the interaction of <i>Candida glabrata</i> with human neutrophils.
Author URL.
Linde J, Duggan S, Weber M, Horn F, Sieber P, Hellwig D, Riege K, Marz M, Martin R, Guthke R, et al (2015). Defining the transcriptomic landscape of <i>Candida glabrata</i> by RNA-Seq.
NUCLEIC ACIDS RESEARCH,
43(3), 1392-1406.
Author URL.
Duggan S, Leonhardt I, Huenniger K, Kurzai O (2015). Host response to <i>Candida albicans</i> bloodstream infection and sepsis.
VIRULENCE,
6(4), 316-326.
Author URL.
Huenniger K, Essig F, Duggan S, Mokhtari Z, Brandes S, Figge MT, Kurzai O (2015). Human neutrophils act differentially on the human fungal pathogens <i>Candida albicans</i> and <i>Candida glabrata</i>.
Author URL.
Duggan S, Essig F, Huenniger K, Mokhtari Z, Bauer L, Lehnert T, Brandes S, Haeder A, Jacobsen ID, Martin R, et al (2015). Neutrophil activation by <i>Candida glabrata</i> but not <i>Candida albicans</i> promotes fungal uptake by monocytes.
CELLULAR MICROBIOLOGY,
17(9), 1259-1276.
Author URL.